Development and validation of dried blood spots technique for quantitative determination of topiramate using liquid chromatography-tandem mass spectrometry

Biomedical Chromatography

Volumn 27, Issue 8, 2013, Pages 1054-1061

  Vnučec Popov, Tanja ^a   Maričič, Lea Cvitkovič ^a   Prosen, Helena ^b   Vončina, Darinka Brodnjak ^c  

^a KRKA D D   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c UNIVERSITY OF MARIBOR   (Slovenia)

Author keywords

Dried blood spots; Liquid chromatography tandem mass spectrometry; Pharmacokinetic study; Topiramate

Indexed keywords

BLOOD; DRUG PRODUCTS; EXTRACTION; MASS SPECTROMETRY;

DRIED BLOOD SPOT; INTERNAL STANDARDS; LC-MS-MS; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; PHARMACOKINETIC STUDIES; QUANTITATIVE DETERMINATIONS; SPOT SAMPLES; TOPIRAMATE; WHOLE BLOOD;

NEGATIVE IONS;

ANION; METHANOL; TOPIRAMATE; WATER;

ACCURACY; ARTICLE; BLOOD VOLUME; DILUTION; DRIED BLOOD SPOT TESTING; DRUG DETERMINATION; FOOD AND DRUG ADMINISTRATION; HEMATOCRIT; HUMAN; LIQUID CHROMATOGRAPHY; PRACTICE GUIDELINE; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; STANDARD; TANDEM MASS SPECTROMETRY; VALIDATION STUDY;

EID: 84880287260     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.2905     Document Type: Article

References (17)

1. Abbott R, Smeraglia J, White S, Luedtke S, Brunet L, Thomas E, Globig S and Timmerman P. Connecting strategies on dried blood spots. Bioanalysis 2010; 2(11): 1809-1816.
2. Bahrami G, Mirzaeei S, Mohammadi B and Kiani A. High performance liquid chromatographic determination of topiramate in human serum using UV detection. Journal of Chromatography B 2005; 822: 322-325.
3. Chen S and Carvey PM. Rapid approach to the quantitative determination of topiramate (2, 3:4, 5-bis-O-(1-methylethylidene)-β-d-fructopyranose sulfamate) in human plasma by liquid-liquid extraction and flow-injection negative-ion electrospray mass spectrometry. Rapid Communications in Mass Spectrometry 1999; 13: 1980-1984.
4. Chen S and Carvey PM. Validation of liquid-liquid extraction followed by flow-injection negative ion electrospray mass spectrometry assay to Topiramate in human plasma. Rapid Communications in Mass Spectrometry 2001; 15: 159-163.
5. Christensen J, Hojskov CS and Poulsen JH. Liquid chromatography tandem mass spectrometry assay for topiramate analysis in plasma and cerebrospinal fluid: validation and comparison with fluorescence-polarization immunoassay. Therapeutic Drug Monitoring 2002; 24(5): 658-664.
6. EMEA. Guideline on Bioanalytical Method Validation. Committee for Medicinal Products for Human Use (CHMP). Document reference EMEA/CHMP/EWP/1992217/2009. European Medicines Agency, 2011.
7. FDA. Guidance for Industry: Bioanalytical Method Validation. Department of Health and Human Services, Food and Drug Administration, 2001. Available from: www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070107.pdf
8. Guthrie R and Suzi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 1963; 32: 338-343.
9. la Marca G, Malvagia S, Filippi L, Fiorini P, Innocenti M, Luceri F, Pieraccini G, Moneti G, Francese S, Dani FR and Guerrini R. Rapid assay of topiramate in dried blood spots by a new liquid chromatography-tandem mass spectrometric method. Journal of Pharmaceutical and Biomedical Analysis 2008; 48: 1392-1396.
10. Li W and Tse FLS: Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules. Biomedical Chromatography 2010; 24: 49-65.
11. Matar KM. Therapeutic drug monitoring of topiramate by liquid chromatography-tandem mass spectrometry. Clinica Chimica Acta 2010; 411: 729-734.
12. Park JH, Park YS, Lee MH, Rhim SY, Song JC, Lee SJ, Kim JM, Shaw LM and Kang JS. Determination of plasma topiramate concentration using LC-MS/MS for pharmacokinetic and bioequivalence studies in healthy Korean volunteers. Biomedical Chromatography 2008; 22: 822-829.
13. Shank R, Gardocki J, Streeter A and Maryanoff B. An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia 2000; 41: S3-9.
14. Tai SSC, Yeh CY and Phinney KW. Development and validation of a reference measurement procedure for certification of phenytoin, phenobarbital, lamotrigine, and topiramate in human serum using isotope dilution liquid chromatography/tandem mass spectrometry. Analytical and Bioanalytical Chemistry 2011; 401: 1915-1922.
15. Timmerman P, White S, Globig S, Lüdtke S, Brunet L and Smeraglia J. EBF recommendation on the validation of bioanalytical methods for dried blood spots. Bioanalysis 2011; 3(14): 1567-1575.
16. Vu DH, Koster RA, Alffenaar JWC, Brouwers JRBJ and Uges DRA. Determination of moxifloxacin in dried blood spots using LC-MS/MS and the impact of the hematocrit and blood volume. Journal of Chromatography B 2011; 879: 1063-1070.
17. Wolf CE, Crooks R and Poklis A. Rapid gas chromatographic procedure for the determination of topiramate in serum. Journal of Analytical Toxicology 2000; 24: 661-663.